Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/GRIN stock hub

CSE/GRIN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/GRINis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

127.5M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/GRIN

In the news

Latest news · CSE/GRIN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/E52.4

P25 7.4P50 15.6P75 34.3

ROE18.7

P25 -121.5P50 -40.9P75 0.5

ROIC-1

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/GRIN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

191

Groups with data

Currency

USD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 152.6M
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA39986R1064
Last refreshed	2026-05-10
Market cap	CAD 127.5M
Price	CAD 0.51
Price currency	CAD
Sector	Healthcare
Sic	0100
Symbol	cse/GRIN
Website	https://www.grownrogue.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.86%
EV Earnings	64.33x
EV/FCF	-102.17x
EV/Sales	3.43x
FCF yield	-1.17%
P/B ratio	3.89x
P/E ratio	52.35x
P/S ratio	2.87x
PE Ratio3 Y	26.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.83%
EBITDA Margin	0.34%
Gross margin	42.64%
Gross Profit	CAD 19M
Gross Profit Growth	7.11%
Gross Profit Growth Q	141.7%
Gross Profit Growth3 Y	11.82%
Gross Profit Growth5 Y	58.58%
Net Income	CAD 2.4M
Net Income Growth Years	1%
Net Income Growth3 Y	46.49%
Pretax Margin	14.91%
Profit Margin	5.33%
Profitable Years	1
ROA	-0.68
ROCE	-1.04
ROE	18.73
ROIC	-1.05
Roic5y	14.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-12.08%
Cagr3y	42.83%
Cagr5y	23.86%
EPS Growth Years	1
EPS Growth3 Y	27.92
OCF Growth	36.51%
OCF Growth3 Y	41.52%
Revenue Growth	21.81x
Revenue Growth Q	203x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	28.67x
Revenue Growth5 Y	56.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.6
Assets	CAD 86M
Cash	CAD 15.6M
Current Assets	CAD 30.3M
Current Liabilities	CAD 7.8M
Debt	CAD 36.6M
Debt EBITDA	CAD 245
Debt Equity	CAD 1.12
Debt FCF	CAD -24.49
Equity	CAD 32.8M
Interest Coverage	-0.43
Liabilities	CAD 53.2M
Long Term Assets	CAD 55.7M
Long Term Liabilities	CAD 45.4M
Net Cash	CAD -21M
Net Cash By Market Cap	CAD -16.46
Net Debt EBITDA	CAD 141
Net Debt Equity	CAD 0.64
Tangible Book Value	CAD 24.5M
Tangible Book Value Per Share	CAD 0.1
WACC	-0.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.87
Inventory Turnover	2.86
Net Working Capital	CAD 11.9M
Quick ratio	2.49
Working Capital	CAD 22.6M
Working Capital Turnover	CAD 8.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-12.07%
200-day SMA	0.52
3Y total return	191.43%
50-day SMA	0.45
50-day SMA vs 200-day SMA	50under200
5Y total return	191.43%
All Time High	1.15
All Time High Change	-55.65%
All Time High Date	2024-05-17
All Time Low	0.06
All Time Low Change	750%
All Time Low Date	2019-11-14
ATR	0.04
Beta	-1.12
Beta1y	-0.14
Beta2y	1.02
Ch YTD	-27.14
High	0.53
High52	0.72
High52 Date	2026-01-02
High52ch	-29.17%
Low	0.49
Low52	0.38
Low52 Date	2026-03-27
Low52ch	34.21%
Ma50ch	14.09%
Price vs 200-day SMA	-2.6%
RSI	56.6
RSI Monthly	47.34
RSI Weekly	50.97
Sharpe ratio	0.23x
Sortino ratio	0.44
Total Return	-19.78%
Tr YTD	-27.14
Tr1m	29.11%
Tr1w	8.51%
Tr3m	-8.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -813,742
Operating margin	-1.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	154,072,257%
Net Borrowing	13,784,059.5
Shares Insiders	14.86%
Shares Out	249,938,980
Shares Qo Q	-2.26%
Shares Yo Y	19.78%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -4.8M
Average Volume	53,759.85x
Bv Per Share	0.11
CAPEX	CAD -6.4M
Ch1m	29.11
Ch1w	8.51
Ch1y	-12.07
Ch3m	-8.93
Ch3y	191.4
Ch5y	191.4
Ch6m	4.08
Change	4.08%
Change From Open	-3.77
Close	0.49
Days Gap	8.16
Depreciation Amortization	960,021.8
Dollar Volume	12,730.1
Earnings Date	2026-05-12
EBIT	CAD -813,742
EBITDA	CAD 149,138
EPS	CAD 0.01
F Score	4
FCF	CAD -1.5M
FCF EV Yield	-0.98x
FCF Per Share	CAD -0.01
Financing CF	13,211,701
Fiscal Year End	December
Founded	1,978
Graham Number	0.1586
Graham Upside	-68.9
Income Tax	CAD 2.2M
Investing CF	-9,262,454
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2018-11-26
Last Split Type	Reverse
Lynch Fair Value	CAD 0.24
Lynch Upside	-52.25
Ma150	0.5
Ma150ch	2.04%
Ma20	0.49
Ma20ch	4.94%
Net CF	8,849,381
Next Earnings Date	2026-05-12
Open	0.53
P OCF Ratio	26.04
Position In Range	55.56
Ppne	37,552,806.1
Price Date	2026-05-08
Price EBITDA	CAD 855
Ptbv Ratio	5.2
Relative Volume	0.39x
Revenue	44,462,592x
SBC By Revenue	7.38x
Share Based Comp	3,282,453
Tax By Revenue	4.94x
Tax Rate	33.17%
Tr6m	4.08%
Volume	24,961
Z Score	1.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/GRIN pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/GRIN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/GRIN?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+14.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+19.8%

Negative means the company is buying back shares.

Technical

CSE/GRIN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.6

Neutral momentum band

Price vs 200-day MA

-2.6%

50/200-day relationship not available

Beta (5Y)

-1.12

Less volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/GRIN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/GRIN stock rating?

cse/GRIN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/GRIN analysis?

The full report lives at /stocks/cse/GRIN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/GRIN?

The latest report frames cse/GRIN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/GRIN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.